Evidence map›Paper›PMID 39095468›Full record

Trial reportEye (London, England)2024

A cross-over, randomised feasibility study of digitally-printed versus hand-painted artificial eyes in adults: PERSONAL-EYE-S.

Amie Woodward, Elizabeth Coleman, Sarah Ronaldson, Tim Zoltie, Paul Bartlett, Laura Wilson, Tom Archer, Jessica Kawalek, Florien Boele, Bernard Chang and 6 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Eye (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Amie WoodwardYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Elizabeth ColemanYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Sarah RonaldsonYork Trials Unit, Department of Health Sciences, University of York, York, UK.
Tim ZoltieSchool of Dentistry, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Paul BartlettMaxillofacial Laboratory, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Laura WilsonLeeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Tom ArcherLeeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Jessica KawalekLeeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.
Florien BoeleLeeds Institute of Medical Research at St James's, St James's University Hospital, University of Leeds, Leeds, UK.
Bernard ChangDepartment of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
George KalantzisDepartment of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Mike TheakerPatient and Public Involvement representative, Leeds, UK.
Nabil El-HindyDepartment of Ophthalmology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Emma WalshawLeeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Taras GoutLeeds Artificial Eye Service, Leeds Dental Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Judith WatsonYork Trials Unit, Department of Health Sciences, University of York, York, UK. jude.watson@york.ac.uk.ORCID http://orcid.org/0000-0003-0694-3854

Funding

DH | NIHR | Research for Patient Benefit Programme (NIHR Research for Patient Benefit Programme) NIHR201559
6 · The paper itself

Abstract

BACKGROUND/

objectivesOver 60,000 patients in the United Kingdom are estimated to have artificial eyes. Manufacturing and hand-painting of artificial eyes have not changed significantly since 1948. Delays and colour-matching issues may severely impact a patient's rehabilitation pathway. Technology advances mean alternatives are now possible. This cross-over, randomised feasibility trial aimed to determine the feasibility of conducting a full-scale trial of the effectiveness and cost-effectiveness of digitally-printed artificial eyes compared to hand-painted. SUBJECTS/

methodsPatients aged ≥18 years who were longstanding artificial eye users requiring a replacement were randomised to receive either a hand-painted or digitally-printed eye first followed by the other type of eye. Participants were asked to approach a close contact (CC) willing to participate alongside them. A subset of participants, their CCs, and staff were interviewed about their opinions on trial procedures, artificial eyes, delivery times and satisfaction.

resultsThirty-five participants were randomised and 10 CCs consented. Participant retention at final follow-up was 85.7%. Outcome data completion rates ranged from 91-100%. EQ-5D-5L completion ranged from 83-97%. Resource-use completion ranged from 0-94% with total costs at £347 for hand-painted and £404 for digitally-printed eye. There were two adverse events. Twelve participants, five CCs, and five staff were interviewed. There were positive and negative features of both types of eyes. We identified that social and psychological wellbeing is affected, often for many years after eye removal. Participation in the feasibility study was well accepted.

conclusionsThe feasibility study outcomes indicate that a full trial is achievable. TRIAL REGISTRATION NUMBER: ISRCTN85921622.

Indexed as

Cost-Benefit AnalysisCross-Over StudiesEye, ArtificialFeasibility StudiesAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPatient SatisfactionProsthesis DesignQuality of LifeUnited Kingdom

Identifiers

PMID39095468
PMCPMC11584860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.